Latest News

April 18, 2012
Time magazine has named Gladstone and UCSF scientist Robert Grant, MD, MPH, to the 2012 TIME 100, the magazine’s annual list of the world’s 100 most influential people.
March 23, 2012
Physical violence, sexual abuse and other forms of childhood and adult trauma are major factors fueling the epidemic of HIV/AIDS among American women, who account for at least 27 percent of new U.S. cases.
March 23, 2012
To effectively confront the HIV/AIDS epidemic in Oakland, the medical community needs to connect with African-American young men, who are a particularly vulnerable group of individuals who may not know they are at high risk and may not be receiving the information they need to protect themselves.
March 14, 2012
President Barack Obama appointed UCSF AIDS expert Grant Colfax, MD, as the director of the Office of National AIDS Policy.
February 29, 2012
A drug once taken by people with HIV/AIDS, but long ago shelved after newer, modern antiretroviral therapies became available, has now shed light on how the human body uses its natural immunity to fight the virus — work that could help uncover new targets for drugs.
February 17, 2012
Paul Volberding, MD, one of the world's leading experts on treatment for patients infected with HIV, the AIDS virus, became the new director of the AIDS Research Institute (ARI) at UCSF on Feb. 13.
February 10, 2012
Tenofovir, one of the most effective and commonly prescribed antiretroviral medications for HIV/AIDS, is associated with a significant risk of kidney damage and chronic kidney disease that increases over time, according to a study of more than 10,000 patients led by researchers at the San Francisco VA Medical Center and UCSF.
February 10, 2012
Scientists at the San Francisco VA Medical Center and the University of California, San Francisco have published a study showing that one of the most effective and commonly prescribed antiretroviral medications for HIV/AIDS, tenofovir, is associated with a significant risk of kidney damage and chronic kidney disease that increases over time. See accompanying news release, Tenofovir, Leading HIV Medication, Linked with Risk of Kidney Damage.
December 21, 2011
In perhaps the most comprehensive survey of the inner workings of HIV, an international team of scientists led by researchers at UCSF has mapped every apparent physical interaction the virus makes with components of the human cells it infects — work that may reveal new ways to design future HIV/AIDS drugs.
December 14, 2011
Scientists at the Gladstone Institutes have discovered new protein fragments in semen that enhance the ability of HIV, the virus that causes AIDS, to infect new cells—a discovery that one day could help curb the global spread of this deadly pathogen.

Pages